Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Scott Schmid

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
NPJ Vaccines|October 25, 2022
Development of antibody-dependent cellular cytotoxicity in response to recombinant and live-attenuated herpes zoster vaccinesSeong Yeon Park, Myron J Levin, Jennifer Canniff, et al.
Pediatrics|May 29, 2013
Breast milk-acquired cytomegalovirus infection and disease in VLBW and premature infantsTatiana M Lanzieri, Sheila C Dollard, Cassandra D Josephson, et al.
The Journal of Infectious Diseases|December 24, 2010
Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccineBarbara A Pahud, Carol A Glaser, Cornelia L Dekker, et al.
Journal of the Neurological Sciences|February 23, 2010
Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literatureAaron Haug, Ravi Mahalingam, Randall J Cohrs, et al.
The Journal of Infectious Diseases|May 4, 2023
Predictors of 5-Year Persistence of Antibody Responses to Zoster VaccinesAdriana Weinberg, D Scott Schmid, Jessica Leung, et al.
Journal of Virology|September 16, 2006
Complete-genome phylogenetic approach to varicella-zoster virus evolution: genetic divergence and evidence for recombinationPeter Norberg, Jan-Ake Liljeqvist, Tomas Bergström, et al.
Clinical and Vaccine Immunology : CVI|September 16, 2011
National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG aviditySheila C Dollard, Stephanie A S Staras, Minal M Amin, et al.
The Pediatric Infectious Disease Journal|February 25, 2011
Laboratory characteristics of suspected herpes zoster in vaccinated childrenColleen Chun, Sheila Weinmann, Karen Riedlinger, et al.
Journal of the Neurological Sciences|September 20, 2011
Reactivation of type 1 herpes simplex virus and varicella zoster virus in an immunosuppressed patient with acute peripheral facial weaknessJean Tsai, Randall J Cohrs, Maria A Nagel, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 31, 2007
Detection and differentiation of wild-type and vaccine mutant varicella-zoster viruses using an Invader Plus methodYi-Wei Tang, Hatim T Allawi, Marlene DeLeon-Carnes, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
NPJ Vaccines|October 25, 2022
Development of antibody-dependent cellular cytotoxicity in response to recombinant and live-attenuated herpes zoster vaccinesSeong Yeon Park, Myron J Levin, Jennifer Canniff, et al.
Pediatrics|May 29, 2013
Breast milk-acquired cytomegalovirus infection and disease in VLBW and premature infantsTatiana M Lanzieri, Sheila C Dollard, Cassandra D Josephson, et al.
The Journal of Infectious Diseases|December 24, 2010
Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccineBarbara A Pahud, Carol A Glaser, Cornelia L Dekker, et al.
Journal of the Neurological Sciences|February 23, 2010
Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literatureAaron Haug, Ravi Mahalingam, Randall J Cohrs, et al.
The Journal of Infectious Diseases|May 4, 2023
Predictors of 5-Year Persistence of Antibody Responses to Zoster VaccinesAdriana Weinberg, D Scott Schmid, Jessica Leung, et al.
Journal of Virology|September 16, 2006
Complete-genome phylogenetic approach to varicella-zoster virus evolution: genetic divergence and evidence for recombinationPeter Norberg, Jan-Ake Liljeqvist, Tomas Bergström, et al.
Clinical and Vaccine Immunology : CVI|September 16, 2011
National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG aviditySheila C Dollard, Stephanie A S Staras, Minal M Amin, et al.
The Pediatric Infectious Disease Journal|February 25, 2011
Laboratory characteristics of suspected herpes zoster in vaccinated childrenColleen Chun, Sheila Weinmann, Karen Riedlinger, et al.
Journal of the Neurological Sciences|September 20, 2011
Reactivation of type 1 herpes simplex virus and varicella zoster virus in an immunosuppressed patient with acute peripheral facial weaknessJean Tsai, Randall J Cohrs, Maria A Nagel, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 31, 2007
Detection and differentiation of wild-type and vaccine mutant varicella-zoster viruses using an Invader Plus methodYi-Wei Tang, Hatim T Allawi, Marlene DeLeon-Carnes, et al.
Pageof 12